Carlino, M.S. et al. (2015) New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma. Journal of Clinical Oncology, 33(11), e52-e56. (doi: 10.1200/JCO.2013.51.5783) (PMID:24821886)
Full text not currently available from Enlighten.
Abstract
No abstract available.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Biankin, Professor Andrew |
Authors: | Carlino, M.S., Kwan, V., Miller, D.K., Saunders, C.A.B., Yip, D., Nagrial, A.M., Tomlinson, J., Grimmond, S.M., Scolyer, R.A., Kefford, R.F., Biankin, A.V., and Long, G. V. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | Journal of Clinical Oncology |
Journal Abbr.: | J. Clin. Oncol. |
Publisher: | American Society of Clinical Oncology |
ISSN: | 0732-183X |
ISSN (Online): | 1527-7755 |
University Staff: Request a correction | Enlighten Editors: Update this record